Search research articles
Contact Us
Filters
Showing results (1-10 of 14) with videos related to
Page
of 2
Sort By:
The Journal of Infectious Diseases
|
September 1, 1988
Clinical bleeding and beta-lactam antibiotics
E R Kessler
Occupational Medicine (Philadelphia, Pa.)
|
November 14, 1997
Vaccine-preventable diseases in health care
E R Kessler
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone
Cassandra Duarte, A Jimeno, E R Kessler
Drugs of Today (Barcelona, Spain : 1998)
|
December 8, 2011
Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib)
D W Bowles, E R Kessler, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)
|
October 31, 2012
Axitinib, a new therapeutic option in renal cell carcinoma
E R Kessler, D W Bowles, T W Flaig, et al.
Research Involvement and Engagement
|
April 11, 2026
Method to engage invested partners to co-create feasible and sustainable approaches to design and implement cancer prevention and control tools
M Pérez Jolles, R E Glasgow, R Gomes, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
June 27, 2017
Cabozantinib use in renal cell carcinoma
A J Neuwelt, S Mathur, A T Johnson, et al.
Journal of the American Dental Association (1939)
|
May 1, 1984
Use of orally administered diazepam in the reduction of dental anxiety
J P Baker, H J May, D A Revicki, et al.
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA
A Seyedroudbari, E R Kessler, A N Mooss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate
E R Kessler, D Gao, T W Flaig, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 14) with videos related to
Sort By:
Page
of 2
The Journal of Infectious Diseases
|
September 1, 1988
Clinical bleeding and beta-lactam antibiotics
E R Kessler
Occupational Medicine (Philadelphia, Pa.)
|
November 14, 1997
Vaccine-preventable diseases in health care
E R Kessler
Drugs of Today (Barcelona, Spain : 1998)
|
February 12, 2019
Abiraterone acetate to treat metastatic castration-resistant prostate cancer in combination with prednisone
Cassandra Duarte, A Jimeno, E R Kessler
Drugs of Today (Barcelona, Spain : 1998)
|
December 8, 2011
Multi-targeted tyrosine kinase inhibitors in clinical development: focus on XL-184 (cabozantinib)
D W Bowles, E R Kessler, A Jimeno
Drugs of Today (Barcelona, Spain : 1998)
|
October 31, 2012
Axitinib, a new therapeutic option in renal cell carcinoma
E R Kessler, D W Bowles, T W Flaig, et al.
Research Involvement and Engagement
|
April 11, 2026
Method to engage invested partners to co-create feasible and sustainable approaches to design and implement cancer prevention and control tools
M Pérez Jolles, R E Glasgow, R Gomes, et al.
Drugs of Today (Barcelona, Spain : 1998)
|
June 27, 2017
Cabozantinib use in renal cell carcinoma
A J Neuwelt, S Mathur, A T Johnson, et al.
Journal of the American Dental Association (1939)
|
May 1, 1984
Use of orally administered diazepam in the reduction of dental anxiety
J P Baker, H J May, D A Revicki, et al.
Journal of Thrombosis and Thrombolysis
|
March 23, 2000
Time to treatment and cost of thrombolysis: a multicenter comparison of tPA and rPA
A Seyedroudbari, E R Kessler, A N Mooss, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 21, 2017
Phase II study of cabazitaxel with or without abiraterone acetate and prednisone in patients with metastatic castrate resistant prostate cancer after prior docetaxel and abiraterone acetate
E R Kessler, D Gao, T W Flaig, et al.
Page
of 2